Prognostic value of neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte ratios and Glasgow prognostic score in osteosarcoma: A meta-analysis

Table 2 Results of meta-analysis

	No. of studies	HR	95%CI	P value	I2(%)	P value
Neutrophil/lymphocyte ratio
Overall survival	11	1.88	1.38-2.55	< 0.001	80.2	< 0.001
Disease-free survival	5	1.67	1.37-2.04	< 0.001	35.4	0.186
Platelet/lymphocyte ratio
Overall survival	7	1.29	0.97-1.72	0.085	77.4	< 0.000
Disease-free survival	2	1.12	0.87-1.44	0.396	0.0	0.465
Lymphocyte/monocyte ratio
Overall survival	6	0.82	0.54-1.23	0.338	70.8	0.004
Disease-free survival	2	0.68	0.41-1.11	0.124	76.1	0.041
Glasgow prognostic score
Overall survival	4	2.19	1.64-2.94	< 0.001	0.0	0.602
Disease-free survival	2	2.50	1.39-4.48	< 0.001	0.0	0.342

HR: Hazard ratio; CI: Confidence interval.